A Two-way Crossover Study Of The Effect Of Food On The Pharmacokinetics Of Pazopanib In Cancer Patients

PHASE1CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

September 21, 2006

Primary Completion Date

June 19, 2009

Study Completion Date

June 19, 2009

Conditions
Carcinoma, Renal Cell
Interventions
DRUG

Pazopanib (GW786034)

Pazopanib (GW786034)

Trial Locations (2)

46202

GSK Investigational Site, Indianapolis

48201

GSK Investigational Site, Detroit

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY